Abstract
AbstractHere, we report the results of experiments regarding the chemical repositioning of 4‐(2‐hydroxyethyl)‐1‐piperazine ethane sulfonic acid (HEPES), a representative buffering agent. In this work, we confirmed that HEPES could disaggregate amyloid plaques, a hallmark of Alzheimer's disease, and we verified its sustained‐release system (release for up to 2 weeks) via hybridization with a biocompatible polymer (Eudragit S100).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
